Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. Founded in 1932 by Henry and Esther Schein as a storefront pharmacy in Queens, NY, the company has grown to become a worldwide distributor of medical and dental supplies including vaccines, pharmaceuticals, financial services, and equipment.
With approximately 26,000 Team Schein Members worldwide, Henry Schein provides more than 1 million customers globally with over 300 valued solutions that help improve operational success and clinical outcomes in the health care sector. The firm offers Business, Clinical, Technology, and Supply Chain solutions tailored to office-based dental and medical practitioners, dental laboratories, government and institutional health care clinics, as well as other alternate care sites. Headquartered in Melville, NY, Henry Schein operates through a centralized and automated distribution network, offering a selection of more than 300,000 branded products and in-house products. A Fortune 500 company and member of the S&P 500® index, Henry Schein generated $12.3 billion in revenue in 2023. The company remains committed to supporting health care providers through innovative solutions around the world.
United States only
Spain only
